Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis

The optimal concurrent chemotherapy regimen with radiotherapy for esophageal cancer is unknown. Here, we compared the survival outcomes and toxicity of definitive chemoradiotherapy with either cisplatin/5-fluorouracil (PF) or docetaxel/cisplatin (DP) in patients with unresectable esophageal squamous...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Zhang, Peng, Xi, Mian, Li, Qiao-Qiao, Hu, Yong-Hong, Guo, Xiaobo, Zhao, Lei, Liu, Hui, Liu, Shi-Liang, Luo, Li-Ling, Liu, Qing, Liu, Meng-Zhong
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Clinical Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5190128/
https://ncbi.nlm.nih.gov/pubmed/27183916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9301
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars